Xinlu Wang
Impact in
- Oncology top 10%
- Peptidase Inhibition and Analysis
Papers in
- Oncology 25
- Peptidase Inhibition and Analysis 16
-
- Pulmonary Hypertension Research and Treatments 4
- Co-authors
- Qi Fang (3 shared papers)Hai‐Quan Mao (1 shared paper)Kam W. Leong (1 shared paper)Jiaji Mao (1 shared paper)Yongming Chen (1 shared paper)Hanshi Xu (1 shared paper)Bo Peng (1 shared paper)Huiyi Liang (1 shared paper)
- Journals
- European Journal of Nuclear Medicine and Molecular Imaging (11 papers)World Journal of Surgical Oncology (3 papers)Advanced Functional Materials (2 papers)Organic Chemistry Frontiers (2 papers)Frontiers in Bioengineering and Biotechnology (2 papers)
- Partner nations
- ChinaUnited StatesNorway
In The Last Decade
Xinlu Wang
97 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 108
- Oncology 223
- Cancer Research 113
- Hepatology 51
- Rehabilitation 42
- Immunology 137
Countries citing papers authored by Xinlu Wang
This map shows the geographic impact of Xinlu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinlu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinlu Wang more than expected).
Fields of papers citing papers by Xinlu Wang
This network shows the impact of papers produced by Xinlu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinlu Wang. The network helps show where Xinlu Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xinlu Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 181 | |
| 2 | 2021 | 88 | |
| 3 | 2019 | 72 | |
| 4 | 2023 | 59 | |
| 5 | 2014 | 43 | |
| 6 | 2012 | 37 | |
| 7 | 2019 | 35 | |
| 8 | 2021 | 31 | |
| 9 | 2018 | 31 | |
| 10 | 2021 | 26 | |
| 11 | 2016 | 24 | |
| 12 | 2020 | 22 | |
| 13 | 2021 | 22 | |
| 14 | 2014 | 22 | |
| 15 | 2024 | 21 | |
| 16 | 2023 | 19 | |
| 17 | 2013 | 19 | |
| 18 | 2019 | 19 | |
| 19 | 2018 | 18 | |
| 20 | 2024 | 16 |
About Xinlu Wang
Xinlu Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Rheumatology, having authored 105 papers that have together received 1.2k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (16 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Medical Imaging Techniques and Applications (5 papers), Protease and Inhibitor Mechanisms (4 papers), Pulmonary Hypertension Research and Treatments (4 papers), Cardiac Structural Anomalies and Repair (4 papers), Urologic and reproductive health conditions (3 papers) and Neuropeptides and Animal Physiology (3 papers). The work is most often cited by research in Oncology (223 citations), Cancer Research (113 citations), Hepatology (51 citations), Rehabilitation (42 citations) and Immunology (137 citations). Xinlu Wang has collaborated with scholars based in China, United States and Norway. Frequent co-authors include Qi Fang, Hai‐Quan Mao, Kam W. Leong, Jiaji Mao, Yongming Chen, Hanshi Xu, Bo Peng, Huiyi Liang, Cong Dong and Lixin Liu. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, World Journal of Surgical Oncology, Advanced Functional Materials, Organic Chemistry Frontiers and Frontiers in Bioengineering and Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.